Boostani Reza, Lotfinejad Nasim, Zemorshidi Fariba, Vahidi Zohreh, Rezaee Seyed Abdolrahim, Farid Reza, Rafatpanah Houshang
Department of Neurology, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Research, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Iran J Basic Med Sci. 2021 Mar;24(3):264-266. doi: 10.22038/ijbms.2021.50803.11562.
Prevention and treatment of the Human T-cell leukemia virus, type 1 (HTLV-1) which was discovered nearly 40 years ago, still remain challenging. The reported high prevalence of HTLV-1 in some countries around the world triggered an open letter to the World Health Organization (WHO), urging action against HTLV-1 infection in 2018. This highlights the importance of virus elimination strategies to eradicate HTLV-1 infection. In Iran, we have documented our experiences with the virus in order to achieve and promote the possible ways to manage, control, and eliminate HTLV-1. Although there has been considerable progress apropos of HTLV-1, a series of additional challenges need to be tackled to control HTLV-1 infection in Iran.
近40年前发现的1型人类T细胞白血病病毒（HTLV-1）的预防和治疗仍然具有挑战性。据报道，HTLV-1在世界上一些国家的高流行率引发了一封致世界卫生组织（WHO）的公开信，敦促在2018年采取行动应对HTLV-1感染。这凸显了消除病毒策略对根除HTLV-1感染的重要性。在伊朗，我们记录了我们应对该病毒的经验，以实现并推广管理、控制和消除HTLV-1的可能方法。尽管在HTLV-1方面已经取得了相当大的进展，但在伊朗控制HTLV-1感染仍需要应对一系列其他挑战。
